Evogene Ltd.
EVGN
$1.06
$0.010.47%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.66% | 106.47% | -91.52% | 22.84% | 39.12% |
| Total Depreciation and Amortization | 383.33% | -10.56% | -68.38% | -90.73% | 2.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 323.79% | -939.69% | 306.60% | -196.12% | 180.79% |
| Change in Net Operating Assets | 548.68% | -195.25% | 70.67% | -85.20% | -204.19% |
| Cash from Operations | 57.82% | 12.12% | -29.16% | -7.15% | 38.82% |
| Capital Expenditure | 92.00% | -274.42% | 36.57% | 79.84% | 4.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -130.51% | 1,916.00% | -44.20% | 141.60% | 1,801.48% |
| Cash from Investing | -130.81% | 1,594.54% | -44.65% | 140.63% | 16,663.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 42.68% | 2.83% | 49.76% | -15.46% | -- |
| Issuance of Common Stock | 5,060.24% | 1,335.56% | -31.37% | 22.06% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.00% | -100.00% | 13.79% | -99.95% | -100.58% |
| Cash from Financing | 2,847.68% | 399.32% | -31.00% | -101.45% | -23.30% |
| Foreign Exchange rate Adjustments | 228.57% | -107.07% | 139.29% | 84.30% | 71.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.31% | 160.74% | -74.18% | 12.14% | 137.15% |